One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer-Reference-Cited by-同舟云学术

One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer

Published:2022-07-22 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Steenbrugge Jonas¹²^ORCID,Bellemans Julie¹,Vander Elst Niels¹,Demeyere Kristel¹,De Vliegher Josephine¹,Perera Timothy³,De Wever Olivier²⁴,Van Den Broeck Wim⁵,De Spiegelaere Ward²⁵,Sanders Niek N.²⁶,Meyer Evelyne¹²

Affiliation:

1. Laboratory of Biochemistry, Department of Veterinary and Biosciences, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium

2. Cancer Research Institute Ghent (CRIG), Ghent, Belgium

3. OCTIMET Oncology NV, Beerse, Belgium

4. Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium

5. Department of Morphology, Imaging, Orthopedics, Rehabilitation and Nutrition, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium

6. Laboratory of Gene Therapy, Department of Veterinary and Biosciences, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium

Funder

Koning Boudewijnstichting

Research Foundation Flanders

Publisher

Informa UK Limited